Literature DB >> 21425873

Probing elongating and branching β-D-galactosyltransferase activities in Leishmania parasites by making use of synthetic phosphoglycans.

Olga V Sizova1, Andrew J Ross, Irina A Ivanova, Vladimir S Borodkin, Michael A J Ferguson, Andrei V Nikolaev.   

Abstract

Protozoan parasites of the genus Leishmania synthesize lipophosphoglycans (LPGs), phosphoglycans and proteophosphoglycans that contain phosphosaccharide repeat units of [-6)Gal(β1-4)Man(α1-OPO(3)H-]. The repeat structures are assembled by sequential addition of Manα1-OPO(3)H and β-Gal. In this study, an UDP-Gal-dependent activity was detected in L. donovani and L. major membranes using synthetic phospho-oligosaccharide fragments of lipophosphoglycan as acceptor substrates. Incubation of a microsomal preparation from L. donovani or L. major parasites with synthetic substrates and UDP-[6-(3)H]Gal resulted in incorporation of radiolabel into these exogenous acceptors. The [(3)H]galactose-labeled products were characterized by degradation into radioactive, low molecular mass fragments upon hydrolysis with mild acid and treatment with β-galactosidases. We showed that the activity detected with L. donovani membranes is the elongating β-d-galactosyltransferase associated with LPG phosphosaccharide backbone biosynthesis (eGalT). The eGalT activity showed a requirement for the presence of at least one phosphodiester group in the substrate and it was enhanced dramatically when two or three phosphodiester groups were present. Using the same substrates we detected two types of galactosyltransferase activity in L. major membranes: the elongating β-d-galactosyltransferase and a branching β-d-galactosyltransferase (bGalT). Both L. major enzymes required a minimum of one phosphodiester group present in the substrate, but acceptors with two or three phosphodiester groups were found to be superior.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21425873      PMCID: PMC3659391          DOI: 10.1021/cb100416j

Source DB:  PubMed          Journal:  ACS Chem Biol        ISSN: 1554-8929            Impact factor:   5.100


  33 in total

Review 1.  Leishmaniasis: new approaches to disease control.

Authors:  Clive R Davies; Paul Kaye; Simon L Croft; Shyam Sundar
Journal:  BMJ       Date:  2003-02-15

2.  Quantitation of protein.

Authors:  C M Stoscheck
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

3.  Structure of the lipophosphoglycan from Leishmania major.

Authors:  M J McConville; J E Thomas-Oates; M A Ferguson; S W Homans
Journal:  J Biol Chem       Date:  1990-11-15       Impact factor: 5.157

4.  Refined structure of the lipophosphoglycan of Leishmania donovani.

Authors:  J R Thomas; M J McConville; J E Thomas-Oates; S W Homans; M A Ferguson; P A Gorin; K D Greis; S J Turco
Journal:  J Biol Chem       Date:  1992-04-05       Impact factor: 5.157

5.  Structure of the major carbohydrate fragment of the Leishmania donovani lipophosphoglycan.

Authors:  S J Turco; S R Hull; P A Orlandi; S D Shepherd; S W Homans; R A Dwek; T W Rademacher
Journal:  Biochemistry       Date:  1987-09-22       Impact factor: 3.162

6.  Transmission of cutaneous leishmaniasis by sand flies is enhanced by regurgitation of fPPG.

Authors:  Matthew E Rogers; Thomas Ilg; Andrei V Nikolaev; Michael A J Ferguson; Paul A Bates
Journal:  Nature       Date:  2004-07-22       Impact factor: 49.962

7.  Persistence without pathology in phosphoglycan-deficient Leishmania major.

Authors:  Gerald F Späth; Lon-Fey Lye; Hiroaki Segawa; David L Sacks; Salvatore J Turco; Stephen M Beverley
Journal:  Science       Date:  2003-08-29       Impact factor: 47.728

8.  Cell-free biosynthesis of lipophosphoglycan from Leishmania donovani. Characterization of microsomal galactosyltransferase and mannosyltransferase activities.

Authors:  M A Carver; S J Turco
Journal:  J Biol Chem       Date:  1991-06-15       Impact factor: 5.157

9.  Infectivity and attenuation of Leishmania donovani promastigotes. II: Association of the loss of parasite infectivity with the terminal galactosylation of precursor acceptors present in virulent parasites by the developmentally regulated galactosyltransferase.

Authors:  S Bhaumik; R Basu; S Roy; T De
Journal:  Parasite Immunol       Date:  2003-10       Impact factor: 2.280

Review 10.  Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda.

Authors:  Philippe J Guerin; Piero Olliaro; Shyam Sundar; Marleen Boelaert; Simon L Croft; Philippe Desjeux; Monique K Wasunna; Anthony D M Bryceson
Journal:  Lancet Infect Dis       Date:  2002-08       Impact factor: 25.071

View more
  1 in total

Review 1.  Synthetic neoglycoconjugates of cell-surface phosphoglycans of Leishmania as potential anti-parasite carbohydrate vaccines.

Authors:  A V Nikolaev; O V Sizova
Journal:  Biochemistry (Mosc)       Date:  2011-07       Impact factor: 2.487

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.